Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07465198 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Autologous Stem Cell Therapy in Patients With Multiple System Atrophy

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study investigates the safety and efficacy of autologous stem cell therapy in patients with Multiple System Atrophy (MSA), a rare and progressive neurodegenerative disorder characterized by autonomic failure, parkinsonism, and cerebellar ataxia. The trial will evaluate functional outcomes, motor performance, and quality of life compared to placebo/controlled group.
Trial Details
NCT Number NCT07465198
Lead Sponsor Biocells Medical
Conditions
(from sponsor)		 MSA - Multiple System Atrophy, MSA
Related terms Multiple System Atrophy, Shy-Drager Syndrome
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov